Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDci Advisors Regulatory News (DCI)

Share Price Information for Dci Advisors (DCI)

Share Price is delayed by 15 minutes
Get Live Data
4.70    0.00 (0.00%)
Bid:
4.60
Ask:
4.80
Spread: 0.20 (4.348%)
Market Cap: £42.52m
DCI Live PriceLast checked at - London Stock Exchange

Intraday Dci Advisors Share Chart

Update on legal actions

13 Dec 2023 08:46

RNS Number : 6335W
DCI Advisors Limited
13 December 2023
 

DCI Advisors Limited

(the "Company")

 

 

Update on legal actions with Dolphin Capital Partners Limited ("DCP")

 

13 December 2023

 

The Board of DCI Advisors Ltd ("DCI" or the "Company") provides the following update on all current legal disputes between the Company and its former Investment Manager, DCP, and DCP's close business partners. The background for these legal disputes is that the Company terminated the Investment Management Agreement dated 1 December 2021 (the "IMA") between the Company and DCP on 20 March 2023 on the basis of a repudiatory breach of contract by DCP for failing to disclose a share option contract in relation to the sale of the Amanzoe resort in 2018 (the "Undisclosed Share Option Agreement").

 

1. The most recent development is the filing of criminal charges in Greece by DCI against Miltos Kambourides, Michael Tsirikos, and some members of staff of DCP and DCP's close business partner Zoniro SA in Greece. These criminal charges were filed on 12 December 2023, and involve allegations of money laundering, and the abuse of corporate governance. In total 9 individual cases were filed as part of these criminal charges.

 

2. In August 2023, DCP's close business partner Zoniro Ltd issued a statutory demand claiming that certain sums were payable to it by DCI and another DCI group company. As background, Zoniro SA (until 2015 part of DCI) used to be DCI's project development manager for its Greek assets until the termination of the agreements with Zoniro by DCI for suspected misconduct. DCI has issued proceedings in the Commercial Court in the BVI to formally set aside the two statutory demands, and has explained in its court filings the close relationship between DCP and Zoniro and evidence of collusion between the two to cause harm to DCI. Zoniro has not responded to DCI's proceedings, and is now out of time to do so, suggesting that it has no answer to the allegations set out in DCI's evidence. A hearing is scheduled to be held in the BVI Court in February 2024 when the matter will be determined. Until that time, we do not expect any material developments in those proceedings. Zoniro also started legal proceedings against one of DCI's subsidiaries in Greece, and the Greek affiliate is defending the case vigorously.

 

3. In early April 2023, DCP filed a claim in the High Court of Justice of England and Wales against DCI alleging a repudiatory breach of contract by the Company in relation to the termination of the IMA (the "Commercial Claim") and claiming for unpaid fees. The Company considers the Commercial Claim to be opportunistic, and without merit and is defending it vigorously. The Company filed its defence and counterclaim in June 2023, and it has also applied to accelerate the matter by filing a reverse summary judgment / strike out application to summarily determine the principal points of each party's claims and counterclaims. The reverse summary judgment hearing is scheduled to be held in March 2024.

As the above actions show, the Company will pursue all legal options to defend itself and recover the value arising from the Undisclosed Share Option Agreement and damages from other cases. The directors continue to believe that the value of the Undisclosed Share Option Agreement could be material in the context of the size of the Company, but at this time they are not in a position to be able to put a precise quantum on the Undisclosed Share Option. No accrual has therefore been made in the Company's financial accounts although the costs of all legal actions are accrued as they are incurred.

 

Enquiries

DCI Advisors Ltd

Nicolai Huls / Nick Paris, Managing Directors

 

nickparis@btinternet.com

+44 (0) 7738 470550

Cavendish Capital Markets (Nominated Adviser & Broker)

William Marle / Jonny Franklin-Adams / Edward Whiley / (Corporate Finance)

Pauline Tribe (Sales)

 

 

+44 (0) 20 7220 0500

FIM Capital Limited (Administrator)

Lesley Lennon / Grainne Devlin (Corporate Governance)

llennon@fim.co.im / gdevlin@fim.co.im

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDTJBPTMTIBMFJ
Date   Source Headline
29th May 20262:11 pmRNSResult of AGM
29th May 202610:48 amRNSHolding(s) in Company
27th May 202610:44 amRNSResult of AGM
19th May 202612:47 pmRNSAGM - FURTHER UPDATE
18th May 20264:35 pmRNSAMENDED AGM Update
18th May 20262:42 pmRNSAGM Update
12th May 202611:56 amRNSBusiness Update
8th May 20264:00 pmRNSNotice of AGM
17th Apr 20263:41 pmRNSTR Major Holding Notification
30th Mar 20262:08 pmRNSUnaudited Condensed Consolidated Interim Accounts
20th Mar 20264:12 pmRNSChange of Board Committee members
31st Dec 20251:29 pmRNSAnnual Financial Report
31st Dec 20251:29 pmRNSAnnual Financial Report
28th Oct 20258:52 amRNSCorrection to Directorate Change announcement
23rd Oct 20258:22 amRNSDirectorate Change
10th Oct 20251:36 pmRNSResult of EGM and Directorate Changes
29th Sep 20259:39 amRNSTR-1 Standard form- notification of major holdings
26th Sep 20259:17 amRNSExtraordinary General Meeting Update
25th Sep 20258:57 amRNSShareholder Update
12th Sep 202512:48 pmRNSFinal Settlement & Resolution of legal disputes
29th Aug 202512:18 pmRNSFurther Re Shareholder Loan
28th Aug 20252:22 pmRNSShareholder Loan
22nd Aug 20252:13 pmRNSUpdate - final pmt to be rec'd from Mr Aristodemou
11th Aug 20259:08 amRNSExtraordinary General Meeting Update
8th Jul 20252:33 pmRNSExtraordinary General Meeting Update
2nd Jul 202512:31 pmRNSSale of Apollo Heights land in Cyprus
12th Jun 20252:20 pmRNSTR1-Standard form - notification of major holdings
11th Jun 202512:51 pmRNSLoan to the Company and Apt. of Alt. Director
21st May 20254:37 pmRNSShareholder Loan
21st May 20253:10 pmRNSSecond cash payment received from Mr Aristodemou
19th May 20257:00 amRNSExtraordinary General Meeting Update
16th May 20254:24 pmRNSShareholder Loans & Related Party Transactions
7th May 202510:29 amRNSTransfer of land plots
30th Apr 20253:45 pmRNSSale of Apollo Heights land in Cyprus
22nd Apr 20252:34 pmRNSEGM Update & Location Change
15th Apr 20252:46 pmRNSNotification - change in substantial shareholding
28th Mar 20253:29 pmRNSUnaudited Interim Results to 31 December 2024
26th Mar 20259:13 amRNSExtraordinary General Meeting Update
27th Feb 20255:07 pmRNSResult of AGM
25th Feb 20257:00 amRNSExtraordinary General Meeting Update
21st Feb 20252:10 pmRNSSale of interests
10th Feb 20254:22 pmRNSNotice of AGM
24th Jan 20257:30 amRNSRestoration - DCI Advisors Ltd
23rd Jan 20255:30 pmRNSHalf-year Report
15th Jan 20258:00 amRNSReadmission - DCI Advisors Ltd
8th Jan 20258:00 amRNSSchedule One Update - DCI Advisors Limited
7th Jan 20256:05 pmRNSFurther update on Re-domicile Timings
7th Jan 202511:00 amRNSSchedule One Update - DCI Advisors Limited
6th Jan 20254:33 pmRNSUpdate on Re-domicile Timings
20th Dec 202411:54 amRNSGeneral Meeting Requisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.